Multiplex Human Papillomavirus L1L2 virus-like particle antibody binding assay
Authors:
Open Access
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Evaluation of serological assays to monitor antibody responses to single-dose HPV vaccinesVaccine, 2020
- Sensitivity of Human Papillomavirus (HPV) Lineage and Sublineage Variant Pseudoviruses to Neutralization by Nonavalent Vaccine AntibodiesThe Journal of Infectious Diseases, 2019
- Durability of the neutralizing antibody response to vaccine and non-vaccine HPV types 7 years following immunization with either Cervarix® or Gardasil® vaccineVaccine, 2019
- Immunogenicity of HPV prophylactic vaccines: Serology assays and their use in HPV vaccine evaluation and developmentVaccine, 2018
- Development and evaluation of multiplexed immunoassay for detection of antibodies to HPV vaccine typesJournal of Immunological Methods, 2015
- A Randomized, Observer-Blinded Immunogenicity Trial of Cervarix® and Gardasil® Human Papillomavirus Vaccines in 12-15 Year Old GirlsPLOS ONE, 2013
- Human Papillomavirus Antibody Reference Reagents for Use in Postvaccination Surveillance SerologyClinical and Vaccine Immunology, 2012
- Neutralization of non-vaccine human papillomavirus pseudoviruses from the A7 and A9 species groups by bivalent HPV vaccine seraVaccine, 2011
- Multiplexed Serologic Assay for Nine Anogenital Human Papillomavirus TypesClinical and Vaccine Immunology, 2010
- Validation of serological assays for diagnosis of infectious diseasesScientific and Technical Review, 1998